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SarcoidosisAbstract Background: Besides clarifying the etiology of unidentiﬁed lymphadenomegaly, punc-
turing hilar and mediastinal lymph nodes by a ﬂexible bronchoscopic needle is an aid in diagnosing
and staging bronchogenic cancer or other metastatic cancers and diagnosing other inﬂammatory
diseases i.e. sarcoidosis tuberculosis.
Objective: Our study had the principal objective to evaluate the positivity of transbronchial nee-
dle aspiration (TBNA).
Method: We retrospectively reviewed 36 patients using bronchoscopy and histopathological
reports and corresponding patients chart over 3 years from January, 2009 to December, 2012 at
the department of chest disease at Mansoura University.
Results: A total of 38 underwent FFB procedures. 2 (5%) patients were excluded due to incom-
plete follow up data.
The yield of TBNA was positive in 22 patients (61%), of them 9 patients (25%) were positive for
malignancy and 13 patients (36%) were diagnosed as inﬂammatory disease i.e. tuberculosis or sar-
coidosis.
Only 3 patients (8%) had documented bleeding after TBNA and, bleeding stopped sponta-
neously. No mortality was reported due to this procedure.
Conclusion: Our study indicated that this method is safe, easy to perform, with a minimum of
complications and useful for the diagnosis and staging of pulmonary neoplasms and mediastinal
lymph node enlargement.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Transbronchial needle aspiration (TBNA) is a valuable tech-
nique for sampling mediastinal lymph node and pulmonary
parenchymal lesion. The diagnostic yield of TBNA variesrculosis.
746 H.M.S. Samaha et al.widely in reported cases ranging from 20% to 90%. It is a safe,
cheap and minimally invasive procedure, performed via a
ﬂexible bronchoscope [1–7].
Indications for TBNA are any enlarged lymph node lining
the trachea or main bronchi or a parenchymal lesion abutting
the main or segmental bronchi out lined by a CT scan or X-ray
chest. The gold standard for histologic diagnosis is mediastino-
scopy, mediastinotomy or an open lung biopsy however these
procedures are invasive and complications can be serious [8].
The objective of this study was to report our 3 years experi-
ence with diagnostic yield and complication of the trans-
bronchial needle aspiration biopsy at Mansoura University
Chest Department.
Methods
Study subjects
All patients were retrospectively reviewed using bronchoscopy
and histopathological reports and corresponding patient chart
over 3 years from January, 2009 to December, 2012 at the
department of chest disease at Mansoura University.
Each FFB was completed by a pulmonary physician under
a consultant’s supervision at the endoscopy unit. Demographic
data were recorded including: age, gender, indication for pro-
cedure, pre-medication, radiographic ﬁndings, bronchoscopy
ﬁndings, pathological diagnosis, and complications of
bronchoscopy.
All selected patients had no accessible peripheral lymph
node, not previously diagnosed as malignancy or other inﬂam-
matory diseases like tuberculosis or sarcoidosis. They had
tracheobronchial wall adjacent lymph node. A written consent
was obtained from each patient prior to the procedure.
Bronchoscopy procedure
Patients were maintained without oral intake for at least 6 h
prior to the procedure. Platelet count prothrombin time (PT)
and activated partial thromboplastin time (aPTT) were
extracted before the procedure and with normal values.
The procedure was performed using a ﬂexible ﬁberoptic
bronchoscopy (Pentax FV_18v, Japan) on the patient in supine
position. Just before insertion of the bronchoscope, 2–3 ml of
2% viscous lidocaine was applied to the nose or lidocaine
spray into oral cavity. Midazolam (0.07 mg/kg) was adminis-
tered intravenously in incremental doses to achieve conscious
sedation, before and after the insertion of the bronchoscope.
All patients were supplemented with oxygen through nasal
cannula and were continuously monitored with electro-
cardiogram and pulse oximetry. Liquid xylocaine 2% was
administered through the bronchoscope directly to the vocalTable 1 Diagnostic yield of various bronchoscopy procedures.
Total no. of procedures
performed (N)
% of
in all
TBNA 36 100
BAL 36 100
Bronchial mucosa biopsy 22 61
Sputum 18 50cords and the bronchial tree as needed. Bronchoalveolar lavage
(BAL), transbronchial needle aspiration (TBNA; lymph nodes
or lung), bronchial mucosa biopsy (TBB), were performed as
decided by the bronchoscopist. Transbronchial needle aspira-
tion (TBNA) was performed blindly and as per the interna-
tional recommendations [9]. Postbronchospy sputum was
collected and sent for sputum cytology. Post-bronchoscopy
chest X-ray and ABG were performed routinely 4 h after
TBLB. In situations where TBNA has to be performed, before
bronchial mucosa biopsy to avoid contamination. The TBNA
needles used were the 20-gauge and 19-gauge needles and nee-
dle length 12 mm. The TBNA needle was advanced to penetrate
through the intercartilaginous space. Then suction was applied
with a 20-ml syringe and the needle was moved in and out by 3–
4 mm. Complications were categorized as minor or major
according to the BTS guidelines [9]. All bronchoscopies were
done without ﬂuoroscopy. Biopsy specimens were ﬁxed in
formaldehyde solution, embedded in parafﬁn, and BAL was
centrifuged and was subsequently ﬁxed and stained on a glass
slide. Direct smear technique was used for the preparation of
TBNA specimens. The specimen was smeared on a glass slide
applying pressure from the same syringe and immediately
covered with a second slide and while exerting gentle continu-
ous pressure the slides were drawn apart and ﬁxed with 95%
alcohol.
Statistical analysis
Data were analyzed using Statistical Package for the Social
Sciences (SPSS) version 16 software package. Continuous vari-
able was expressed as mean ± SD categorical variables were
tested using Chi-square test. Signiﬁcance was taken at 0.05.
Results
A total of 38 underwent FFB procedures. 2 (5%) patients were
excluded due to incomplete follow up data.
The mean age of 36 was 48 ± 13 and 19 (53%) were males,
cigarette smokers account for 16 (44%) of studied patients. 18
(50%) had received medication pre procedure in the form of
oral steroid and other non speciﬁc medication.
Malignancy was suspected through history and radiological
ﬁnding in 10 (28%) of the studied groups.
8 patients (22%) of the studied group had posterior
mediastinal lesion, 6 patients (17%) had anterior mediastinal
lesion, 17 patients (47%) had mediastinal and subcarnial
lymph node and 5 patients (14%) had both lymph node
enlargement and lung inﬁltration (see Table 1).
The yield of TBNA was positive in 22 patients (61%), of
them 9 patients (25%) were positive for malignancy and 13
patients (36%) were diagnosed as inﬂammatory disease i.e.procedures performed
patients (n)
No. of positive
results (n)
Yield
(n/N · 100%)
22 61
18 50
14 63
6 33
Transbronchial lymph node aspiration 747tuberculosis or sarcoidosis. BAL was a positive diagnosis of
malignancy performed in 18 patients (50%) and presented as
follows: malignancy 12 (33%), inﬂammatory 6 (17%).
Bronchial mucosa biopsy was done only to 22 (61%) patients
of the studied cases and its yield was positive in 14 (63%) as fol-
lows: 6 (27%) malignant and 8 (36%) inﬂammatory.
Post bronchoscopy sputum cytology was performed in 18
patients (50%) and its yield was positive in 6 cases (33%)
two of them (11%) were malignant the last four (22%) were
inﬂammatory.
Mean of number of slides used to diagnose TBNA showed
4 ± 1.8 with a signiﬁcant difference between them.
There was no correlation between number of slides used in
TBNA and diagnostic yield of TBNA.
Only 3 patients (8%) had documented bleeding after TBNA
and, bleeding stopped spontaneously. No mortality was
reported due to this procedure.Discussion
Transbronchial needle aspiration, which was ﬁrst developed by
Schieppati [10], and later used with the ﬁberoptic broncho-
scope [11], is now beginning to gain acceptance as an essential
tool to stage the extent of mediastinal lymph node involvement
in malignant disease.
The positive yield obtained in our study was 61%, whereas
results from other studies have demonstrated a positive yield
of 45–96% [1,3,11,12].
The varied positive yield obtained from different studies
suggests that transbronchial needle aspiration was not only
operator-dependent [13], but also depended on other factors
to achieve high yields. These factors are likely to include the
type of needle, technique, tomographic evaluation, tissue pre-
paration, tissue interpretation, nodal site and size [14].
In our study it was reported that lymph node aspiration
was not separate. According to the site of lymph node and size
it is required to examine each aspirate separately so further
studies are needed to determine the yield of each lymph node.
This suggests that separation of the transbronchial needle
aspiration specimens according to different nodal stations
may be helpful in staging lung cancer and determining appro-
priate subsequent treatment.
In our study there was no correlation between numbers of
slides used in TBNA and diagnostic yield. Tissue preparation
and interpretation are important factors to consider for
achieving a high TBNA diagnostic yield [15].
With regard to sample preparation, two widely practiced
methods were compared prospectively by Diacon et al. [16] to
determine which has a higher yield. In the ﬁrst method, the
specimens were ﬂushed into a container and transported as a
ﬂuid suspension to the laboratory, where they were processed
further (called the ﬂuid technique), while in the second method,
the specimen was directly placed onto a slide, and immediately
smeared and spray-ﬁxed (called the direct technique). They
reported that the direct technique had a better yield overall
than the ﬂuid technique (p< 0.01). The direct technique is
superior because the ﬂuid technique may have resulted in cell
loss during transportation and laboratory preparation.
We reported only 3 patients (8%) out of 36 patients had
documented bleeding after TBNA and, bleeding stopped spon-
taneously. No mortality was reported due to this procedure.Therefore, bronchoscopists should consider TBNA as one
of the routine sampling procedures besides bronchial brushing
and endobronchial forceps biopsy, as serious complications
following TBNA are rare.
Since it was adapted for use with ﬂexible bronchoscopy,
transbronchial needle aspiration is a procedure that continues
to undergo improvisation to achieve higher diagnostic yields.
These include guidance techniques, such as CT-ﬂuoroscopy
guided TBNA [17] and endobronchial ultrasound-guided
TBNA [18].
As the trend moves toward minimally invasive techniques,
TBNA is a valuable tool to diagnose lesions in the mediasti-
num and lung; without subjecting the patient to surgery. As
techniques advance with time, so must our skills for surely,
the tool is only as good as its operator.
In malignancy early diagnosis and staging with less invasive
technique through many techniques by bronchoscopy play
important roles in determining appropriate treatment and
thus, inﬂuence the prognosis of this disease.
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